Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 11, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals (Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty) on October 10, 2006. Each individual acquired 8 shares through the personal contribution element and 8 shares through the company matching element of the ShareReward Plan. The transaction price was GBP 14.64 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the specific share transactions described above.
Investor Verification Points
- Verify the total number of shares acquired by each named director (16 shares each: 8 personal, 8 matched).
- Confirm the transaction price of GBP 14.64 per share on October 10, 2006.
- Note that this filing does not contain financial results; investors should refer to Form 20-F or quarterly reports for financial metrics.